Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Cancer Res. 2010 May 25;70(11):4327–4334. doi: 10.1158/0008-5472.CAN-09-3312

Fig. 6. FibFN-mediated tumor cell invasion depends on MT1-MMP.

Fig. 6

(A–B), B16F1 cells were embedded in a 3-dimensional matrix of FibFN and analyzed for invadopodia formation after 16 hours. (A), invasion of FibFN-embedded B16F1 cells after treatment with ε-aminocaproic acid, aprotinin or the broad spectrum MMP inhibitor GM6001. (B), invasion of FibFN-embedded B16F1 cells after treatment with TIMP1, TIMP2 or MT1-MMP siRNA.